ENVIVA INC (EVA) Stock Analyst Ratings
USA - New York Stock Exchange - NYSE:EVA - US29415B1035 - Common Stock
0.4198 USD
+0.01 (+2.22%)
ChartMill assigns a Buy % Consensus number of 45% to EVA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.08. This target is 871.89% above the current price.
EVA was analyzed by 8 analysts. The buy percentage consensus is at 45. So analysts seem to be rather negative about EVA.
In the previous month the buy percentage consensus was at a similar level.
EVA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-11-21 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-11-16 | Raymond James | Downgrade | Strong Buy -> Market Perform |
| 2023-11-10 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-11-10 | JP Morgan | Downgrade | Neutral -> Underweight |
| 2023-10-18 | JP Morgan | Maintains | Neutral -> Neutral |
| 2023-10-04 | Truist Securities | Maintains | Sell -> Sell |
| 2023-10-03 | RBC Capital | Reiterate | Sector Perform -> Sector Perform |
| 2023-10-03 | Raymond James | Maintains | Strong Buy -> Strong Buy |
| 2023-07-11 | Citigroup | Maintains | Buy -> Buy |
| 2023-05-15 | RBC Capital | Maintains | Sector Perform -> Sector Perform |
| 2023-05-05 | Raymond James | Maintains | Strong Buy |
| 2023-05-04 | Truist Securities | Downgrade | Buy -> Sell |
| 2023-04-05 | Raymond James | Maintains | Strong Buy |
| 2023-04-05 | Citigroup | Maintains | Buy |
| 2023-04-04 | Truist Securities | Maintains | Buy |
| 2023-04-04 | Citigroup | Maintains | Buy |
| 2023-03-03 | JP Morgan | Maintains | Neutral |
| 2023-03-02 | Raymond James | Maintains | Strong Buy |
| 2023-02-01 | Truist Securities | Maintains | Buy |
| 2022-11-29 | RBC Capital | Maintains | Sector Perform |
| 2022-10-20 | JP Morgan | Maintains | Neutral |
| 2022-10-18 | Raymond James | Upgrade | Outperform -> Strong Buy |
| 2022-10-14 | Citigroup | Upgrade | Neutral -> Buy |
| 2022-09-15 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2022-08-19 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2022-07-20 | JP Morgan | Maintains | Neutral |
| 2022-05-13 | RBC Capital | Maintains | Outperform |
| 2022-04-19 | JP Morgan | Maintains | Neutral |
| 2022-03-07 | RBC Capital | Maintains | Outperform |
| 2022-03-02 | JP Morgan | Maintains | Neutral |
ENVIVA INC / EVA FAQ
What is the average price target for ENVIVA INC (EVA) stock?
8 analysts have analysed EVA and the average price target is 4.08 USD. This implies a price increase of 871.89% is expected in the next year compared to the current price of 0.4198.
Can you provide the consensus rating for ENVIVA INC stock?
The consensus rating for ENVIVA INC (EVA) is 45 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
Can you provide the analyst count for ENVIVA INC stock?
The number of analysts covering ENVIVA INC (EVA) is 8.